These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15993672)

  • 1. Rational antibiotic treatment of outpatient genitourinary infections in a changing environment.
    David RD; DeBlieux PM; Press R
    Am J Med; 2005 Jul; 118 Suppl 7A():7S-13S. PubMed ID: 15993672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate antibiotic treatment of genitourinary infections in hospitalized patients.
    Liu H; Mulholland SG
    Am J Med; 2005 Jul; 118 Suppl 7A():14S-20S. PubMed ID: 15993673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
    Martinez FJ; Anzueto A
    Am J Med; 2005 Jul; 118 Suppl 7A():39S-44S. PubMed ID: 15993676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of complicated urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Hawboldt J; Brooks A
    Postgrad Med; 2010 Nov; 122(6):7-15. PubMed ID: 21084776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current challenges in the treatment of complicated urinary tract infections and prostatitis.
    Wagenlehner FM; Naber KG
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():67-80. PubMed ID: 16669930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.
    Segreti J; House HR; Siegel RE
    Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
    Talan DA; Naber KG; Palou J; Elkharrat D
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
    Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expanding role of fluoroquinolones.
    Schaeffer AJ
    Dis Mon; 2003 Feb; 49(2):129-47. PubMed ID: 12601342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of rhinosinusitis in the outpatient setting.
    Poole MD; Portugal LG
    Am J Med; 2005 Jul; 118 Suppl 7A():45S-50S. PubMed ID: 15993677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial treatment of lower respiratory tract infections in the hospital setting.
    Grossman RF; Rotschafer JC; Tan JS
    Am J Med; 2005 Jul; 118 Suppl 7A():29S-38S. PubMed ID: 15993675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections.
    Edlund C; Nord CE
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():41-8; discussion 63-5. PubMed ID: 11051623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
    Fraise AP
    J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of antibiotics in chronic bacterial prostatitis.
    Wagenlehner FM; Weidner W; Sörgel F; Naber KG
    Int J Antimicrob Agents; 2005 Jul; 26(1):1-7. PubMed ID: 15970433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of receipt of a fluoroquinolone versus trimethoprim-sulfamethoxazole for treatment of acute pyelonephritis in women in Manitoba, Canada.
    Carrie AG; Metge CJ; Collins DM; Harding GK; Zhanel GG
    Pharmacoepidemiol Drug Saf; 2004 Dec; 13(12):863-70. PubMed ID: 15386718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolones: how to use (but not overuse) these antibiotics.
    Sable CA; Scheld WM
    Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar.
    Randrianirina F; Soares JL; Carod JF; Ratsima E; Thonnier V; Combe P; Grosjean P; Talarmin A
    J Antimicrob Chemother; 2007 Feb; 59(2):309-12. PubMed ID: 17138569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriologic diagnosis and antibiotic therapy of urinary tract infections].
    Caron F
    Rev Prat; 2003 Oct; 53(16):1760-9. PubMed ID: 14702817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic decisions: assessing clinical fit.
    Barriere SL
    Pharmacotherapy; 1993; 13(2 Pt 2):18S-22S. PubMed ID: 8474933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.